Literature DB >> 15829401

Infection-induced apoptosis deletes bystander CD4+ T cells: a mechanism for suppression of autoimmunity during BCG infection.

Richard A O'Connor1, Susan Wittmer, Dyana K Dalton.   

Abstract

Infection with Mycobacterium bovis Bacille Calmette Guérin (BCG) induces high levels of apoptosis among activated CD4+ T cells. We have investigated the specificity of this pro-apoptotic response and its influence on CD4+ T cell mediated autoimmunity. Apoptosis induced by BCG-infection is unrelated to antigenic specificity, as demonstrated by the increased apoptosis of activated TCR transgenic CD4+ T cells of unrelated specificity. Moreover, infection-induced apoptosis promoted the deletion of CD4+ T cells activated either by peptide or anti-CD3/anti-CD28 stimulation. Infection-induced apoptosis required IFN-gamma production by the infected host, and expression of the IFN-gamma receptor on donor CD4+ T cells. We used an adoptive transfer model of experimental autoimmune encephalomyelitis (EAE) to assess the influence of infection-induced apoptosis on a CD4+ T cell-mediated response. A significantly higher level of apoptosis was seen among sorted encephalitogenic CD4+ T cells transferred to BCG-infected versus uninfected hosts. BCG-infected mice displayed a milder course of clinical disease than their uninfected counterparts and a decreased recovery of donor cells from the CNS. The data suggest that mycobacterial infection attenuates the severity of EAE, at least in part, by promoting the apoptotic elimination of autoreactive CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15829401     DOI: 10.1016/j.jaut.2005.01.005

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  7 in total

1.  Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system.

Authors:  Richard A O'Connor; Xujian Li; Seth Blumerman; Stephen M Anderton; Randolph J Noelle; Dyana K Dalton
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

Review 2.  Mycobacteria-induced suppression of autoimmunity in the central nervous system.

Authors:  JangEun Lee; Matyas Sandor; Erika Heninger; Zsuzsanna Fabry
Journal:  J Neuroimmune Pharmacol       Date:  2010-03-24       Impact factor: 4.147

3.  Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells.

Authors:  Hongwei Xu; Zhi-Ying Wu; Fang Fang; Lan Guo; Doris Chen; John Xi Chen; David Stern; Gregory A Taylor; Hong Jiang; Shirley ShiDu Yan
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

4.  Bystander macrophage apoptosis after Mycobacterium tuberculosis H37Ra infection.

Authors:  Deirdre M Kelly; Annemieke M C ten Bokum; Seonadh M O'Leary; Mary P O'Sullivan; Joseph Keane
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

5.  Mycobacterium bovis bacille Calmette-Guérin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner.

Authors:  JangEun Lee; Emily K Reinke; Alla L Zozulya; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

6.  Structural Variability of Lipoarabinomannan Modulates Innate Immune Responses within Infected Alveolar Epithelial Cells.

Authors:  Hanrui Liu; Xuwen Gui; Shixing Chen; Weizhe Fu; Xiang Li; Tingyuan Xiao; Jie Hou; Tao Jiang
Journal:  Cells       Date:  2022-01-21       Impact factor: 6.600

7.  BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis.

Authors:  Sofia Fernanda Gonçalves Zorzella-Pezavento; Clara Pires Fujiara Guerino; Fernanda Chiuso-Minicucci; Thais Graziela Donegá França; Larissa Lumi Watanabe Ishikawa; Ana Paula Masson; Célio Lopes Silva; Alexandrina Sartori
Journal:  Clin Dev Immunol       Date:  2013-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.